The Tetracycline Hydrochloride produced using the world's advanced biotechnological processes ranks at the leading level in the industry for its main indicators. The production license date is December 16, 2020. On April 12, 2024, the company achieved excellent results with a "zero 483" score and passed the U.S. FDA inspection for the tenth time. Tetracycline Hydrochloride has also become a product that has passed the U.S. FDA inspection and is exported to high-end markets in Europe and America.